Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 10/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12534198 | 0.90 | CHRM2 (0.37) | ALDH1A1CHRM2CHRM1CHRM4CHRM3 | |
| SCHEMBL813805 | 0.85 | NPC1 (0.46) | ALDH1A1NPC1RAB9AGAAHPGD | |
| SCHEMBL21400656 | 0.80 | APP (0.44) | NPC1RAB9AHPGD | |
| SCHEMBL1931753 | 0.80 | HPGD (0.40) | ALDH1A1CHRM2CHRM1NPC1RAB9A | |
| SCHEMBL11771503 | 0.78 | MEN1 (0.35) | ALDH1A1CHRM2CHRM1CHRM4CHRM3 | |
| SCHEMBL7231881 | 0.78 | KMT2A (0.40) | NPC1RAB9ASLC6A3 | |
| SCHEMBL7774785 | 0.78 | KMT2A (0.40) | NPC1RAB9ASLC6A3 | |
| SCHEMBL15869184 | 0.77 | TNK2 (0.40) | NPC1RAB9ASLC6A3 | |
| SCHEMBL4390019 | 0.77 | TNK2 (0.40) | NPC1RAB9ASLC6A3 | |
| SCHEMBL3500438 | 0.77 | TNK2 (0.44) | ALDH1A1NPC1RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110137064-A1 | METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS | MEMPILE INC. (US) | 2011-06-09 | — | — | US | disclosed |
| US-20090161516-A1 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MEMPILE INC. (US) | 2009-06-25 | — | — | US | disclosed |
| EP-1888511-A1 | A METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | Mempile Inc. (US) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006117791-A1 | A METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MEMPILE INC. (US) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110137064-A1 | METHACRYLATE-BOUND PHOTOISOMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS | MMAB, TET3, KDM2B | ALDH1A1 1021/4885CHRM2 3604/4885CHRM1 1956/4885 |
| US-20090161516-A1 | METHACRYLATE-BOUND PHOTOISMERIZABLE CHROMOPHORE, METHODS FOR ITS SYNTHESIS AND OF ITS INTERMEDIATES | MMAB, HMBS, KDM2B | ALDH1A1 770/4885CHRM2 4088/4885CHRM1 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.